A Study to Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tumour Malignancies

NCT05629689 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Solid Tumor
Oncology

Interventions

DRUG: GEH200520 Injection / GEH200521 (18F) Injection - Part A
DIAGNOSTIC_TEST: Dynamic and Static - PET/CT scan
DRUG: GEH200520 Injection / GEH200521 (18F) Injection - Part B
DIAGNOSTIC_TEST: Static - PET/CT scan

Sponsor

GE Healthcare